1) meglumine cyclic adenylate
环磷腺苷葡胺
1.
Chuanxiongzine and meglumine cyclic adenylate in the treatment of pulmonary heart disease at decompensatory stage;
川芎嗪与环磷腺苷葡胺治疗肺心病失代偿期
2.
Conclusion Meglumine cyclic adenylate has good clinical efficacy in treatment of patients with chronic congestive heart failure,and it is worthy to be recommended.
目的评价环磷腺苷葡胺治疗慢性充血性心力衰竭的临床疗效。
3.
【Objective】To observe whether the Youniqing(meglumine cyclic adenylate,MCA) could enhance the recovery effect of Amiodarone on paroxysmal atrial fibrillation(AF).
目的观察尤尼清(环磷腺苷葡胺meglumine cyclic adenylate,MCA)加强胺碘酮对阵发性快速心房颤动的转复效果。
2) Meglumine adenosine cyclophosphate
环磷腺苷葡胺
1.
Methods A total of 89 patients were divided into two groups randomly:the control group (44 cases) received the routine treatment and the treated group (45 cases) received the routine treatment and intravenous injection of meglumine adenosine cyclophosphate,120 mg every time,once daily.
目的用6min步行试验和多普勒超声心动图评价环磷腺苷葡胺辅助治疗缺血性心肌病心力衰竭的疗效。
2.
To explore the effects of meglumine adenosine cyclophosphate(MAC)on heart function in pa- tients with heart failure of ischemic cardidmyopathy(ICM).
目的:探讨环磷腺苷葡胺(MAC)对缺血性心肌病(ICM)心力衰竭患者心功能的影响。
3.
Meglumine adenosine cyclophosphate injection(180mg) was added into the prime perfusate during ECC in treated group(n=24),but not in control group(n=24).
目的通过观察体外循环(extracorporeal circulation,ECC)中使用环磷腺苷葡胺心肌停博液对围术期心肌酶学、病理学及临床的影响,探讨其在ECC术中的心肌保护作用。
3) Meglumine cyclic adenylate
环磷腺苷葡甲胺
1.
Meglumine cyclic adenylate treatment for tachycardiomyopathy after radiofrequency catheter ablation;
快速心律失常性心肌病射频消融术后环磷腺苷葡甲胺干预治疗的随机对照研究
2.
Objective To investigate the efficacy and safety of drug compatibility of Isosorbide Dinitrate(ISD), Meglumine cyclic adenylate(MCA)and Potassium Magnesium Aspartate(PMA)in the patients with unstable angina pectoris (UA).
硝酸异山梨酯联合用药组(n=27):硝酸异山梨酯联合环磷腺苷葡甲胺(心先安)、门冬氨酸钾镁(潘南金),静滴,每天1次,连续10d;对照组(n=30):给予常规UA治疗。
4) Xinxianan injection
环磷腺苷-葡甲胺
1.
Effect of Xinxianan injection on the lung and heart function in chronic Cor Pulmonale patients;
环磷腺苷-葡甲胺治疗肺心病心肺功能不全的临床研究
5) Megluming cyclic adenylate
环磷酸腺苷葡胺
1.
Myocardial protection of Megluming cyclic adenylate on myocardial ischemic and reperfusion injury in patients undergoing valve replacement during cardiopulmonary bypass;
环磷酸腺苷葡胺对心脏瓣膜置换术患者心肌缺血/再灌注损伤心肌保护作用的研究
2.
Objective To investigate the myocardial protection of megluming cyclic adenylate(M-cAMP) during non-cardiac surgery in the patients with coronary artery disease.
目的观察环磷酸腺苷葡胺对冠心病患者行非心脏手术心肌的保护作用。
6) meglumine cyclic adenylate
环磷酸腺苷葡甲胺
1.
Objective: To explore the therapeutic effect of meglumine cyclic adenylate(McAMP) in chronic heart failure(CHF).
目的:探讨心先安(环磷酸腺苷葡甲胺,M cAMP)治疗慢性心力衰竭(CHF)的疗效。
补充资料：环磷腺苷
分子式：暂无
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：用于缓解心绞痛及急、慢性心肌梗塞等病症。
分子量：暂无
CAS号：暂无
性质：暂无
制备方法：暂无
用途：用于缓解心绞痛及急、慢性心肌梗塞等病症。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条